Trial Profile
A PILOT STUDY OF LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH PRIMARY PLASMA CELL LEUKEMIA.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jan 2013
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Plasma cell leukaemia
- Focus Therapeutic Use
- 13 Mar 2012 Additional lead trial center identified as reported by ClinicalTrials.gov.
- 13 Mar 2012 Company added in association field as reported by ClinicalTrials.gov.
- 13 Mar 2012 Actual patient number (23) added as reported by ClinicalTrials.gov.